US Phase I Study of ECT-001-CB in Patients With Sickle-Cell Disease

Stopped Preference given to gene therapy approaches by the SCD research community and patients' associations

Conditions

• Sickle Cell Disease
• Umbilical Cord Blood
• Hematopoietic Cell Proliferation

Interventions

• BIOLOGICAL: ECT-001-CB (UM171-Expanded Cord Blood Transplant)

Sponsor

ExCellThera inc.

Collaborators

• [object Object]